News Medical on MSN3 个月
Why hypoglycemia-induced glucagon secretion becomes impaired in diabetes
In mouse models of type 1 diabetes, the secretion of glucagon for the counter-regulation of blood sugar levels is restored ...
BioWorld2 天
Dual and triple agonists of GCG, GIP and GLP-1 receptors disclosed in Sun Pharmaceutical patent
Sun Pharmaceutical Industries Ltd. has divulged incretin analogues acting as dual agonists of gastric inhibitory polypeptide (GIPR) receptor/GLP-1 or GLP-1/glucagon receptor (GCGR) or triple agonists ...
MBX Biosciences announces phase 1 topline resuts for MBX 1416
MBX Biosciences (MBX) announced positive results from its Phase 1 single ascending dose, SAD, and multiple ascending dose, MAD, clinical trial ...
Business Wire1 个月
Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor ...
About Avexitide Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia ...